Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN PHARMA

23.240
+0.1600.69%
Volume:1.11M
Turnover:25.78M
Market Cap:61.80B
PE:20.46
High:23.320
Open:23.120
Low:22.740
Close:23.080
52wk High:29.000
52wk Low:12.202
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:2.72
T/O Rate:0.21%
Dividend:0.35
Dividend Rate:1.51%
EPS(LYR):1.136
ROE:6.75%
ROA:1.32%
PB:1.17
PE(LYR):20.46
PS:1.43

Loading ...

Fosun Pharma (02196) Announces Poll Results of 2025 First EGM

Bulletin Express
·
Oct 23

600 Million Yuan! Shenzhen Industry Fund Invests in Zhangjiang Company

Deep News
·
Oct 21

Fosun Pharmaceutical Gets US FDA Orphan Drug Designation for Anti-Tumor Drug

MT Newswires Live
·
Oct 20

Fosun Pharma Chairman Chen Yuqing: Leading with Innovation, Steadily Expanding Globally, Supporting Shanghai's "Five Centers" Construction

Deep News
·
Oct 18

Fosun Pharma (02196): Shenzhen Biomedical Industry Fund to Invest 600 Million CNY in Fosun Kerry's Series A Financing

Stock News
·
Oct 17

FOSUN PHARMA-Invested Fund's Incubated Enterprise Secures Over $400 Million Overseas Licensing Deal for Innovative Ophthalmic Gene Therapy

Deep News
·
Oct 15

Fosun Pharmaceutical Unit Withdraws Application for Lung Cancer Drug

MT Newswires Live
·
Oct 15

20 Billion Yuan Jiaxing Pharmaceutical Company Appoints New Chairman

Deep News
·
Oct 11

Hong Kong Stock Alert | HENLIUS (02696) Surges Over 10% as FOSUN PHARMA's Middle East Office Officially Opens in Jeddah, Saudi Arabia

Stock News
·
Oct 08

FOSUN PHARMA (02196) Proposes Appointment of Liu Yi as Executive Director

Stock News
·
Sep 30

Fosun Pharma to Offload Pharmaceutical Manufacturer for 1.26 Billion Yuan

MT Newswires Live
·
Sep 29

Hong Kong Stock Announcements Highlights | MINISO Proposes Spinoff of TOP TOY for Independent Listing on Hong Kong Stock Exchange Main Board

Stock News
·
Sep 28

Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (600196.SH): Plans to Participate in Private Equity Fund Setup and Transfer 100% Equity of Shanghai Clone

Stock News
·
Sep 26

Fosun Pharma Unit's Registration Application for Leukemia Drug Accepted in China

MT Newswires Live
·
Sep 24

FOSUN PHARMA (600196.SH) Subsidiary Receives Approval for Drug Registration Application

Stock News
·
Sep 24

AH Stock Statistics | September 24

Stock News
·
Sep 24

AH Share Premium Statistics | September 22

Stock News
·
Sep 22

Fosun Pharma Gets Nod to Market Bone Treatment Drugs in EU Market; Shares Down 1%

MT Newswires Live
·
Sep 22

FOSUN PHARMA's Blockbuster Innovative Drug Receives Approval for Additional Breast Cancer Indication

Deep News
·
Sep 19

Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (600196.SH): Two Denosumab Injection Products Receive EU Registration Approval

Stock News
·
Sep 19